- Home
- TMP vs AUPH Comparison
TMP vs AUPH Comparison
Compare TMP & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMP
- AUPH
- Stock Information
- Founded
- TMP 1836
- AUPH 1993
- Country
- TMP United States
- AUPH Canada
- Employees
- TMP N/A
- AUPH N/A
- Industry
- TMP Major Banks
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- TMP Finance
- AUPH Health Care
- Exchange
- TMP Nasdaq
- AUPH Nasdaq
- Market Cap
- TMP 892.4M
- AUPH 1.0B
- IPO Year
- TMP N/A
- AUPH 1999
- Fundamental
- Price
- TMP $75.40
- AUPH $8.12
- Analyst Decision
- TMP Buy
- AUPH Strong Buy
- Analyst Count
- TMP 1
- AUPH 3
- Target Price
- TMP $68.00
- AUPH $10.33
- AVG Volume (30 Days)
- TMP 61.7K
- AUPH 1.3M
- Earning Date
- TMP 10-25-2024
- AUPH 11-07-2024
- Dividend Yield
- TMP 3.29%
- AUPH N/A
- EPS Growth
- TMP 376.41
- AUPH N/A
- EPS
- TMP 4.64
- AUPH N/A
- Revenue
- TMP $286,367,000.00
- AUPH $220,361,000.00
- Revenue This Year
- TMP N/A
- AUPH $36.52
- Revenue Next Year
- TMP $6.80
- AUPH $19.02
- P/E Ratio
- TMP $16.24
- AUPH N/A
- Revenue Growth
- TMP 30.04
- AUPH 38.72
- 52 Week Low
- TMP $43.09
- AUPH $4.71
- 52 Week High
- TMP $78.28
- AUPH $10.05
- Technical
- Relative Strength Index (RSI)
- TMP 65.43
- AUPH 62.64
- Support Level
- TMP $73.52
- AUPH $8.06
- Resistance Level
- TMP $76.68
- AUPH $8.70
- Average True Range (ATR)
- TMP 2.71
- AUPH 0.34
- MACD
- TMP 0.56
- AUPH 0.07
- Stochastic Oscillator
- TMP 80.76
- AUPH 63.74
About TMP Tompkins Financial Corporation
Tompkins Financial Corp is a Financial Holding Company. It has three business segments, consisting of banking, insurance and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Insurance is comprised of property and casualty insurance services and employee benefit consulting. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates majority of its revenue from Banking segment.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.